Drug Shortage Report for TEVA-TRIACOMB
Report ID | 125488 |
Drug Identification Number | 00550507 |
Brand name | TEVA-TRIACOMB |
Common or Proper name | TEVA-TRIACOMB CREAM |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TRIAMCINOLONE ACETONIDE NYSTATIN NEOMYCIN GRAMICIDIN |
Strength(s) | 1MG 100000UNIT 2.5MG 0.25MG |
Dosage form(s) | CREAM |
Route of administration | TOPICAL TOPICAL |
Packaging size | 30g |
ATC code | D07CB |
ATC description | CORTICOSTEROIDS, COMB WITH ANTIBIOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-09-30 |
Estimated end date | 2020-11-30 |
Actual end date | 2020-11-06 |
Shortage status | Resolved |
Updated date | 2020-11-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-11-07 | English | Compare |
v4 | 2020-11-06 | French | Compare |
v3 | 2020-11-06 | English | Compare |
v2 | 2020-10-01 | French | Compare |
v1 | 2020-10-01 | English | Compare |
Showing 1 to 5 of 5